Decline in Sexual Functioning Over a 3-Year Period after Hematopoietic Cell Transplantation (HCT): Gender-Specific Impact of Total Body Irradiation (TBI) and Chronic Graft-Versus-Host Disease (cGvHD)

Blood ◽  
2008 ◽  
Vol 112 (11) ◽  
pp. 743-743
Author(s):  
F. Lennie Wong ◽  
Stephen J. Forman ◽  
Liton Francisco ◽  
Mitzi Gonzales ◽  
Melanie Sabado ◽  
...  

Abstract Sexual dysfunction is a multidimensional problem caused by both physiologic and psychosocial factors. Yet little is known about the longitudinal trends of sexual functioning in HCT survivors, or the clinical or psychosocial factors associated with decline. Using a longitudinal study design, we administered the Derogatis Interview for Sexual Functioning (DISF-SR), the Global Sexual Satisfaction Index (GSSI), and the City of Hope-QOL instrument at 5 time points to a large cohort of patients undergoing HCT at City of Hope (COH): prior to HCT, at 6m, 1y-, 2y-, and 3y-post-HCT. DISF-SR assessed 5 domains of sexual functioning (Cognition/Fantasy, Arousal, Behavior/Experiences, Orgasm, and Drive/Relationship), and a Total score. GSSI elicited patients’ subjective appraisal of sexual satisfaction. The COH-QOL instrument was used to obtain self-reported levels of anxiety, distress, depression, pain, physical strength, and sleep changes, which were converted to composite scores of mental and physical stress. Long-term trends of sexual functions were estimated using the Generalized Estimating Equation. We examined the effects of sociodemographic factors, primary diagnosis, HCT conditioning regimens, disease status at HCT, presence of cGvHD, and composite mental and physical stress levels on the longitudinal trends of DISF-SR, the Total score, and GSSI. The cohort included 312 adults (median age at HCT 48y; 56% males) undergoing autologous (n=175) or allogeneic (n=137) HCT for hematologic malignancies or severe aplastic anemia; 144 patients completed the 3y sexual survey (participation rate at 3 years=75%). GSSI (general sexual satisfaction) declined significantly after HCT (p=0.001) for both men and women, and remained depressed over the 3-y study period, with 40% reporting poor or worse sexual satisfaction level at 3y. There were no significant differences between men and women in terms of general sexual satisfaction level. However, the degree of sexual dysfunction as measured by DISF-SR was worse in women than in men for all domains, and for Total score (p<.001) at all post-HCT time points (Fig. 1A). Furthermore, assessment of DISF-SR scores revealed that while men experienced a persistent decline in satisfaction with Orgasm and Drive/Relationship (p<0.05), women did not demonstrate a significant decline in sexual function in any of the domains post-HCT. Gender-specific multivariate analyses revealed certain subgroups that were more vulnerable to a decline in sexual functions after HCT. Notably, older age (≥40y) (Fig. 1B), being married, and TBI exposure in men (Fig. 1C), and older age (≥30y) (Fig. 1D), being overweight, and greater mental and/or physical stress in women were factors identified as significantly associated with decreased sexual functioning following HCT. Although cGvHD was not directly related to DISF-SR or GSSI, presence of cGvHD was accompanied by worse mental and physical composite scores (p<0.0001). Lower mental and/or physical composite scores in turn were significantly related to lower sexual functions for all domains of DISF-SR, the Total score (Fig. 1E) and GSSI in women (p<0.05). Thus, women may be vulnerable to the effects of cGvHD mediated through mental and/or physical stress, in turn resulting in compromised sexual functions and satisfaction after HCT. This study should inform healthcare providers that patients undergoing HCT require more attention to their sexual QOL within the first year after HCT. Routine inquiry of patients’ sexual health should be included in follow-up exams after HCT, especially for those at high risk (i.e. TBI-exposed men and those with cGvHD), with the ability to offer a multidisciplinary approach to managing this distressing complication. Figure Figure

2016 ◽  
Vol 9 (1) ◽  
pp. 158-158
Author(s):  
M. Gómez-Lugo ◽  
◽  
P. Vallejo-Medina ◽  
J. P. Saffón ◽  
D. Saavedra-Roa ◽  
...  

Objective: Sexual dysfunction is an important public health concern. Sexual dysfunctions, characterized by disturbances in sexual desire, arousal, erection, orgasm or sexual satisfaction have been reported in different research around the world. Prevalence range of disturbances is from 20% to 30% and 40% to 45% for men and women respectively. The aim of this study was to explore prevalence of sexual dysfunction in a Colombian male and female sample. Design and Method: Sample was composed by a non-representative national sample of 1366 women and 1410 men, aged from 18 to 73. To assess sexual dysfunction the Colombian version of the Massachusetts General Hospital- Sexual Functioning Questionnaire (MGH-SFQ) was used. Results: Results indicate on one hand that sexual dysfunction is more prevalent in women (42.5%) than men (32.1 %). On the other hand, in women, problems related to desire (28.5%) were more common, while in men those related to desire and sexual satisfaction, 21.4% and 21% respectively, were more prevalent. In women, problems related to desire (28.5%) were more common, while in men those related to desire and sexual satisfaction 21.4% and 21%, respectively were more prevalent. Furthermore, no evidence was found about the relationship between the sociodemographic characteristic (socioeconomic level, years of education and religion) and the sexual dysfunction; with exception of age. These results are similar to those observed in other cultures. Conclusions: This study shows the importance of epidemiologic research in male and female sexual dysfunction for the identification of risk factors.


1978 ◽  
Vol 8 (4) ◽  
pp. 335-345 ◽  
Author(s):  
Judith F. Milne ◽  
Joshua S. Golden ◽  
Lorna Fibus

Eighteen chronic hemodialysis patients were interviewed by staff trained in sex therapy. Compared with the pre-uremic phase, sexual satisfaction was less in nine subjects, greater in four; frequency of intercourse had declined in ten subjects. Dysfunctions of sexual response were reported by five men and six women. Analysis of physical factors, medication and depression showed no clear association with sexual dysfunction, suggesting the importance of psychosocial factors. A trial of sex therapy in renal patients is proposed.


2019 ◽  
Vol 1 (2) ◽  
pp. 117-121 ◽  
Author(s):  
Deepak S. Ghadigaonkar ◽  
Pratima Murthy

Sexual dysfunction is commonly associated with the use of substances, in both men and women. This area requires prominent attention, particularly as the use of substances is often with the expectancy of improving an underlying sexual dysfunction or with a positive expectancy of enhancing sexual function. The chronic use of substances has a negative impact on sexual function and causes various kinds of sexual dysfunction in both men and women. In this narrative review, we look at the effect of various substances of abuse on sexual functioning and discuss management strategies in such situations.


2003 ◽  
Vol 182 (1) ◽  
pp. 50-56 ◽  
Author(s):  
S. Macdonald ◽  
J. Halliday ◽  
T. MacEwan ◽  
V. Sharkey ◽  
S. Farrington ◽  
...  

BackgroundThat sexual dysfunction occurs in schizophrenia is not in doubt. Previous studies have had weaknesses such as the use of selected populations or the absence of a control group.AimsTo measure rates of sexual dysfunction in people with schizophrenia compared with the general population.MethodSexual dysfunction was assessed by a self-completed gender-specific questionnaire. Ninety-eight (73%) of 135 persons with schizophrenia and 81 (71%) of 114 persons recruited as controls returned the questionnaire.ResultsAt least one sexual dysfunction was reported by 82% of men and 96% of women with schizophrenia. Male patients reported less desire for sex, were less likely to achieve and maintain an erection, were more likely to ejaculate more quickly and were less satisfied with the intensity of their orgasms. Female patients reported less enjoyment than the control group. Sexual dysfunction in female patients was associated with negative schizophrenic symptoms and general psychopathology. There was no association between sexual dysfunction and type of antipsychotic medication.ConclusionsPeople with schizophrenia report much higher rates of sexual dysfunction than do the general population. Men and women with schizophrenia have a different pattern of sexual dysfunction.


1998 ◽  
Vol 16 (9) ◽  
pp. 3148-3157 ◽  
Author(s):  
K L Syrjala ◽  
S L Roth-Roemer ◽  
J R Abrams ◽  
J M Scanlan ◽  
M K Chapko ◽  
...  

PURPOSE To describe the prevalence of sexual difficulties in men and women after marrow transplantation (MT), and to define medical, demographic, sexual, and psychologic predictors of sexual dysfunction 3 years after MT. PATIENTS AND METHODS Four hundred seven adult MT patients were assessed pretransplantation. Survivors repeated measures of psychologic and sexual functioning at 1 and 3 years posttransplantation. RESULTS Data were analyzed from 102 event-free 3-year survivors who defined themselves as sexually active. Men and women did not differ in sexual satisfaction pretransplantation. At 1 and 3 years posttransplantation, women reported significantly more sexual dysfunction than men. Eighty percent of women and 29% of men reported at least one sexual problem by 3 years after MT. No pretransplantation variables were significant predictors of 3-year sexual satisfaction for women. For men, pretransplantation variables of older age, poorer psychologic function, not being married, and lower sexual satisfaction predicted sexual dissatisfaction at 3 years (R2=.28; P < .001). Women who were more dissatisfied 3 years after MT did not receive hormone replacement therapy (HRT) at 1 -year posttransplantation and were less satisfied at 1 year, but not pretransplantation (R2=.35; P < .001). CONCLUSION Sexual problems are significant in the lives of MT survivors, particularly for women. Although HRT before 1 year posttransplantation improves sexual function, it does not ensure sexual quality of life. Intervention for women is needed to apply hormonal, mechanical, and behavioral methods to prevent sexual difficulties as early after transplantation as possible.


2011 ◽  
Vol 26 (S2) ◽  
pp. 1376-1376
Author(s):  
Y. El Kissi ◽  
S. Gaabout ◽  
M. Laroussi ◽  
M. Ayachi ◽  
B. Ben Hadj Ali

IntroductionSexual dysfunction is reported by up to 80% of schizophrenic patients and seems to be mainly associated with antipsychotic medications.ObjectiveThis study aimed to compare sexual functioning and sexual dysfunction, as assessed by the Arizona Sexual Experience Scale, in drug naïve or drug free schizophrenic patients and in healthy controls.MethodA consecutive sample of 109 patients meeting DSM-IV criteria of schizophrenia was constituted in psychiatry department of Sousse Farhat Hached hospital (Tunisia), during a 24 months period. They were drug naïve or drug free for at least three months. 109 age and gender matched, consenting controls were recruited among blood donors attending Farhat Hached hospital during the same period. They were free from psychotic disorders as screened by MINI-Plus. Sexual functioning was assessed using the Arizona Sexual Experience Scale (ASEX) in sexually active patients (N = 84) and controls (N = 94).ResultsThere were no statistical differences in sexual dysfunction rates between schizophrenic patients (20.6%) and healthy controls (13.1%), according to usual threshold values. Also, global ASEX score was similar in schizophrenic patients (12.93 ± 4.48) as in healthy controls (12.61 ± 2.60). Besides, different ASEX item scores including sex drive, arousal, vaginal lubrification/penile erection and orgasm have not shown any differences between patients and controls. Only sexual satisfaction score was higher in schizophrenic patients than in healthy controls (2.73 ± 0.95 vs. 2.43 ± 0.77; p = 0.02).ConclusionOur results showed a low rate of sexual dysfunction in drug free schizophrenic patients without statistical differences with healthy controls. Only sexual satisfaction was lower in schizophrenic patients.


2021 ◽  
Vol 30 (1) ◽  
pp. 29-49
Author(s):  
Staša Kukulj ◽  
Gordana Keresteš

The transition to parenthood brings changes in many areas of life, including the area of sexuality. The aim of this study was to examine differences in the frequency of sexual intercourse, sexual satisfaction and the sexual self-schema of participants in different stages of their transition to parenthood. The study involved men and women without children, those who were expecting their first child, and parents of six-month-old and one-year-old children (N = 650). The results showed that participants in different stages of transition to parenthood differed in the frequency of sexual intercourse, but not in their sexual satisfaction and sexual self-schema. Men and women without children and parents of one-year-olds reported more frequent sexual intercourse than those expecting their first child and parents of six-month-old children, although these differences were statistically significant only in the female sample. Men, compared to women, reported more frequent sexual intercourse and greater sexual satisfaction. The research results demonstrate the complexity of sexual functioning during the transition to parenthood and can be applied in providing psychosocial support during this period of life.


2017 ◽  
Vol 35 (5_suppl) ◽  
pp. 210-210 ◽  
Author(s):  
Sharon L. Bober ◽  
Christopher J. Recklitis ◽  
Alexis L. Michaud ◽  
Alexi A. Wright

210 Background: Sexual dysfunction is a distressing long-term effect after ovarian cancer (OC), affecting up to 90% of survivors for years. Despite its prevalence, treatment-related sexual dysfunction is underrecognized and undertreated for OC survivors. We developed and tested a brief, psychoeducational intervention for managing sexual dysfunction after OC. Methods: 45 OC survivors with sexual dysfunction received a single half-day group intervention that included sexual health education, relaxation and cognitive behavioral therapy (CBT) skills to address sexual symptoms and a single tailored telephone booster call 4 weeks post-group. Assessment measures were completed at 4 time points: Baseline 1, Baseline 2 (after an 8 week no-treatment run-in period), and 2 and 6 months post-intervention. The Female Sexual Function Index (FSFI) assessed sexual functioning and the Brief Symptom Inventory (BSI-18) captured psychological distress. Results: Analyses examined changes from Baseline 1 to subsequent time points. Between Baseline 1 and 2 there were no significant changes on study measures, indicating no natural improvement during the run-in period. In contrast, Total FSFI scores improved significantly from Baseline 1 to the 2 month (n = 45, p < .005) and 6 month (n = 35, p < .05) follow-ups. Effect sizes were moderately large indicating a significant improvement in women’s sexual function post- intervention (d = .5) that was sustained for at least 6-months (d = .4). BSI-18 scores were also significantly improved at the 2 -month (p < .005) and 6 month (p < .01) time-points, compared to Baseline 1. Conclusions: Improvements in overall sexual functioning and psychological distress were observed 2 months post-intervention and maintained at 6 month follow-up, suggesting preliminary efficacy of the intervention in reducing sexual dysfunction in OC survivors. Next steps include collection of additional follow-up data on participants. A randomized trial of START-OC is warranted. Clinical trial information: NCT02287519.


Sign in / Sign up

Export Citation Format

Share Document